SEC Form S-8 is a registration filing used by companies to register securities issued to employees under benefit plans. It is filed under the Securities Exchange Act of 1933 to ensure transparent ...
The FDA has approved the first and only cyclin-dependent kinase 4/6 inhibitor for patients with HR-positive metastatic breast cancer, regardless of HER2 status.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results